Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease - Lin et al. 2019

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease

Citation

SY Lin, KJ Lin, PC Lin, CC Huang, CC Chang, YC Lee, IT Hsiao, TC Yen, WS Huang, BH Yang and PN Wang, "Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease", Alzheimer's Research & Therapy (2019) 11:111.

© 2019 Lin, Lin, Lin, Huang, Chang, Lee, Hsiao, Yen, Huang, Yang and Wang

Alzheimer's Research & Therapy | Volume 11, Article 111

Previous
Previous

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease

Next
Next

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology